FDA
-
-
-
-
-
-
-
Parallax Announces Immediate Availability Point-of-Care COVID-19 Diagnostic Testing Kits, Personal Protection Equipment (PPE) and Medical Supplies
-
-
-
-
-
-
-
Parallax Health Sciences' Board of Directors Approves Separation of RoxSan Pharmacy, Inc. and Declares Special Dividend Distribution of RoxSan Stock
-
-
-
-
322,995 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

